Organigram Pauses Some Cannabis Production Over Labeling Dispute
Organigram is one of a number of companies to have received the notification
Canadian cannabis producer Organigram Holdings said it is pausing production of its lozenge product in a 100-milligram THC package pending a resolution over an ongoing dispute with Health Canada.
The Toronto-headquartered company said it received a notification from Health Canada claiming the products were incorrectly classified and labeled as “extract” rather than “edible.”
Organigram is one of a number of companies to have received such a notification this year.
In January, MJBizDaily reported that the federal cannabis regulator had begun asking some licensed marijuana companies to stop selling certain products the agency said were incorrectly classified and labeled as “extracts” rather than “edibles.”
To Read The Rest Of This Article On MJ Biz Daily, Click Here